Aerpio Pharmaceuticals, Inc.
COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
Last updated:
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed. Combination therapy with antibodies and PK/PD data are also disclosed.
Status:
Application
Type:
Utility
Filling date:
29 May 2020
Issue date:
19 Nov 2020